Antiplatelet drug selection in PCI to vein grafts in patients with acute coronary syndrome and adverse clinical outcomes: Insights from the British Cardiovascular Intervention Society database

ConclusionsOur real world national study provides no clear evidence to indicate that use of potent P2Y12 blockers in SVG PCI is associated with improved clinical outcomes.

Source: Catheterization and Cardiovascular Interventions - January 22, 2018 Category: Cardiovascular & Thoracic Surgery Authors: Alex Sirker, Chun Shing Kwok, Evangelos Kontopantelis, Tom Johnson, Philip Freeman, Mark A de Belder, Peter Ludman, Azfar Zaman, Mamas A Mamas Tags: CORONARY ARTERY DISEASE Source Type: research